LSE - Delayed Quote • GBp
e-therapeutics plc (ETX.L)
As of 10:17 AM GMT+1. Market Open.
Breakdown
TTM
1/31/2023
1/31/2022
1/31/2021
Total Revenue
340.00
475.00
477.00
317.00
Gross Profit
340.00
475.00
477.00
317.00
Operating Expense
12,994.00
10,714.00
10,044.00
4,802.00
Operating Income
-12,654.00
-10,239.00
-9,567.00
-4,485.00
Net Non Operating Interest Income Expense
524.00
219.00
51.00
17.00
Pretax Income
-11,882.00
-9,772.00
-9,516.00
-4,468.00
Tax Provision
-1,826.00
-1,498.00
-1,449.00
-784.00
Net Income Common Stockholders
-10,056.00
-8,274.00
-8,067.00
-3,684.00
Diluted NI Available to Com Stockholders
-10,056.00
-8,274.00
-8,067.00
-3,684.00
Basic EPS
-0.02
-0.02
-0.02
-0.01
Diluted EPS
-0.02
-0.02
-0.02
-0.01
Basic Average Shares
568,129.26
537,346.31
488,342.12
373,215.46
Diluted Average Shares
568,129.26
537,346.31
488,342.12
373,215.46
Total Operating Income as Reported
-12,654.00
-10,239.00
-9,567.00
-4,485.00
Total Expenses
12,994.00
10,714.00
10,044.00
4,802.00
Net Income from Continuing & Discontinued Operation
-10,056.00
-8,274.00
-8,067.00
-3,684.00
Normalized Income
-10,056.00
-8,274.00
-8,067.00
-3,684.00
Interest Income
539.00
242.00
61.00
17.00
Interest Expense
15.00
23.00
10.00
--
Net Interest Income
524.00
219.00
51.00
17.00
EBIT
-11,867.00
-9,749.00
-9,506.00
-4,468.00
EBITDA
-11,370.00
-9,281.00
-9,313.00
-4,357.00
Reconciled Depreciation
497.00
468.00
193.00
111.00
Net Income from Continuing Operation Net Minority Interest
-10,056.00
-8,274.00
-8,067.00
-3,684.00
Normalized EBITDA
-11,370.00
-9,281.00
-9,313.00
-4,357.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
1/31/2021 - 11/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVG.L Evgen Pharma plc
0.8000
0.00%
FAB.L Fusion Antibodies plc
3.7000
-1.33%
SYNGENE.BO Syngene International Limited
700.60
+0.24%
FARN.L Faron Pharmaceuticals Oy
135.00
+5.88%
ALBPS.PA Biophytis S.A.
0.0023
+4.55%
BAI.AS BenevolentAI S.A.
0.6600
-2.94%
REDX.L Redx Pharma Plc
8.32
-16.80%
C4XD.L C4X Discovery Holdings plc
12.00
+27.32%
FUM.L Futura Medical plc
35.26
-0.41%
FHTX Foghorn Therapeutics Inc.
5.23
+0.38%